MwanzoGMAB • NASDAQ
add
Genmab
$ 32.36
Baada ya Saa za Kazi:(0.25%)+0.080
$ 32.44
Imefungwa: 28 Nov, 17:00:00 GMT -5 · USD · NASDAQ · Kanusho
Bei iliyotangulia
$ 31.92
Bei za siku
$ 31.46 - $ 32.48
Bei za mwaka
$ 17.24 - $ 33.65
Thamani ya kampuni katika soko
20.54B USD
Wastani wa hisa zilizouzwa
2.10M
Uwiano wa bei na mapato
18.99
Mgao wa faida
-
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.02B | -81.55% |
Matumizi ya uendeshaji wa biashara | 505.00M | -83.96% |
Mapato halisi | 401.00M | -68.33% |
Kiwango cha faida halisi | 39.24 | 71.73% |
Mapato kwa kila hisa | 41.80 | 111.02% |
EBITDA | 473.00M | -78.54% |
Asilimia ya kodi ya mapato | 16.80% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 3.41B | -80.30% |
Jumla ya mali | 7.02B | -82.30% |
Jumla ya dhima | 1.27B | -83.59% |
Jumla ya hisa | 5.75B | — |
hisa zilizosalia | 61.57M | — |
Uwiano wa bei na thamani | 0.34 | — |
Faida inayotokana na mali | 17.02% | — |
Faida inayotokana mtaji | 20.23% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 401.00M | -68.33% |
Pesa kutokana na shughuli | 536.00M | -73.64% |
Pesa kutokana na uwekezaji | -54.00M | -124.11% |
Pesa kutokana na ufadhili | -21.00M | 92.39% |
Mabadiliko halisi ya pesa taslimu | 465.00M | -76.88% |
Mtiririko huru wa pesa | 364.00M | -74.44% |
Kuhusu
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
11 Jun 1998
Tovuti
Wafanyakazi
2,681
